EMMPRIN/CD147, His, Canine
EMMPRIN/CD147, His, Canine

The purity of EMMPRIN/CD147, His, Canine is greater than 95% as determined by SEC-HPLC.

EMMPRIN/CD147, His, Canine

EMMPRIN/CD147, His, Canine on Bis-Tris PAGE under reduced condition. The purity is greater than 95%

EMMPRIN/CD147, His, Canine

CD147, also known as extracellular matrix metalloproteinase inducer (EMMPRIN) or basigin, is expressed in a variety of cell types. It is involved in the regulation of extracellular matrix (ECM) remodeling during physiological and pathological processes including wound healing, inflammatory diseases, and cancer. CD147 is a diagnostic and therapeutic target in cancer and inflammatory diseases, either directly or indirectly, by targeting CD147 partners.
Z04697
¥80,213.00

Ask us a question
Product Introduction
Species Canine
Protein Construction
EMMPRIN/CD147 (Ala22-Arg205)
Accession # XP_533964.2		 His
N-term C-term
Purity > 95% as determined by Bis­Tris PAGE 
> 95% as determined by HPLC
Endotoxin Level Less than 1EU per μg by the LAL method.
Expression System HEK293
Theoretical Molecular Weight 21.54 kDa
Apparent Molecular Weight Due to glycosylation, the protein migrates to 30-45 kDa based on Bis-Tris PAGE result.
Formulation Lyophilized from 0.22μm filtered solution in PBS (pH 7.4).
Reconstitution Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage & Stability Upon receiving, the product remains stable up to 6 months at -20 °C or below. Upon reconstitution, the product should be stable for 3 months at -80 °C. Avoid repeated freeze-thaw cycles.

Examples
  • EMMPRIN/CD147, His, Canine
    • EMMPRIN/CD147, His, Canine

    The purity of EMMPRIN/CD147, His, Canine is greater than 95% as determined by SEC-HPLC.

  • EMMPRIN/CD147, His, Canine
    • EMMPRIN/CD147, His, Canine

    EMMPRIN/CD147, His, Canine on Bis-Tris PAGE under reduced condition. The purity is greater than 95%


Background
Target Background CD147, also known as extracellular matrix metalloproteinase inducer (EMMPRIN) or basigin, is expressed in a variety of cell types. It is involved in the regulation of extracellular matrix (ECM) remodeling during physiological and pathological processes including wound healing, inflammatory diseases, and cancer. CD147 is a diagnostic and therapeutic target in cancer and inflammatory diseases, either directly or indirectly, by targeting CD147 partners.
Synonyms Basigin; BSG; CD147; 5F7; M6; OK; TCSF

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.